Sale!

PTCH1 Gene Basal Cell Nevus Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The PTCH1 Gene Basal Cell Nevus Syndrome NGS Genetic DNA Test is a comprehensive genetic analysis that detects mutations in the PTCH1 gene associated with Gorlin syndrome, also known as basal cell nevus syndrome. This advanced next-generation sequencing test provides crucial information for individuals with a family history of multiple basal cell carcinomas, jaw cysts, or skeletal abnormalities. The test helps identify genetic predisposition to this autosomal dominant condition, enabling early intervention and personalized management strategies. For only $500 USD, patients receive detailed genetic insights that can guide medical decisions and family planning. This test is particularly valuable for individuals experiencing symptoms like multiple basal cell skin cancers before age 30, jaw keratocysts, or characteristic facial features. Understanding your PTCH1 gene status empowers you with knowledge about inheritance patterns and helps healthcare providers develop targeted surveillance protocols.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

PTCH1 Gene Basal Cell Nevus Syndrome NGS Genetic DNA Test

Comprehensive Genetic Analysis for Gorlin Syndrome Detection

The PTCH1 Gene Basal Cell Nevus Syndrome NGS Genetic DNA Test represents a cutting-edge approach to diagnosing Gorlin syndrome, a rare genetic disorder characterized by multiple basal cell carcinomas, jaw cysts, and various skeletal abnormalities. This sophisticated genetic test utilizes next-generation sequencing technology to provide unparalleled accuracy in detecting mutations within the PTCH1 gene, which plays a critical role in the hedgehog signaling pathway essential for normal embryonic development and tissue regulation.

What This Advanced Genetic Test Measures

Our comprehensive NGS-based analysis specifically targets the PTCH1 gene, examining it for pathogenic variants that disrupt normal protein function. The test identifies:

  • Point mutations affecting single nucleotides
  • Small insertions and deletions within the gene sequence
  • Copy number variations that may impact gene dosage
  • Splice site mutations affecting RNA processing
  • Frameshift mutations leading to premature stop codons

Who Should Consider PTCH1 Genetic Testing

This test is particularly recommended for individuals presenting with:

  • Multiple basal cell carcinomas developing before age 30
  • Recurrent jaw keratocysts or odontogenic keratocysts
  • Characteristic facial features including macrocephaly and frontal bossing
  • Palmar or plantar pits on hands and feet
  • Calcification of the falx cerebri visible on brain imaging
  • Family history of Gorlin syndrome or related symptoms
  • Skeletal abnormalities such as bifid ribs or vertebral anomalies
  • Medulloblastoma or other childhood brain tumors

Significant Benefits of Early Genetic Detection

Undergoing PTCH1 genetic testing provides numerous advantages for patients and their families:

  • Early Intervention Opportunities: Enables proactive surveillance and preventive measures before significant complications develop
  • Personalized Management Strategies: Guides dermatological monitoring frequency and treatment approaches
  • Family Planning Guidance: Provides crucial information about inheritance patterns and recurrence risks
  • Comprehensive Risk Assessment: Identifies associated risks for other manifestations like medulloblastoma
  • Psychological Relief: Reduces uncertainty and empowers informed healthcare decisions
  • Multidisciplinary Care Coordination: Facilitates appropriate referrals to dermatology, dentistry, and other specialists

Understanding Your Genetic Test Results

Our comprehensive genetic counseling support helps you interpret your results effectively:

  • Positive Result: Indicates a pathogenic mutation in the PTCH1 gene, confirming Gorlin syndrome diagnosis and guiding personalized management protocols
  • Negative Result: Suggests absence of detectable PTCH1 mutations, though clinical follow-up may still be recommended based on symptoms
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications, requiring ongoing monitoring and potential family studies
  • Inconclusive Result: May necessitate additional testing or alternative diagnostic approaches

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Nationwide Testing Accessibility

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and healthcare professionals ensures you receive expert guidance regardless of your location.

Take Control of Your Genetic Health Today

Don’t let uncertainty about genetic risks impact your health decisions. Our PTCH1 Gene Basal Cell Nevus Syndrome NGS Genetic DNA Test provides the clarity you need for informed medical management and family planning. With a turnaround time of 3-4 weeks and multiple sample collection options including blood, extracted DNA, or simple blood spot cards, accessing this vital genetic information has never been more convenient.

Ready to schedule your genetic test? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Our team is prepared to answer your questions, discuss pre-test genetic counseling requirements, and guide you through the testing process with compassion and expertise.